Mitochondrial defects in cardiomyopathy and neuromuscular disease.
about
Peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1)- and estrogen-related receptor (ERR)-induced regulator in muscle 1 (Perm1) is a tissue-specific regulator of oxidative capacity in skeletal muscle cellsMutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy.Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary oChemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative StressThe LETM1/YOL027 gene family encodes a factor of the mitochondrial K+ homeostasis with a potential role in the Wolf-Hirschhorn syndrome.Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factorTaurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseasesAbsolute quantitation of a heteroplasmic mitochondrial DNA deletion using a multiplex three-primer real-time PCR assay.The mitochondrial DNA T16189C polymorphism and HIV-associated cardiomyopathy: a genotype-phenotype association study.Voltage-dependent anion channel (VDAC) is involved in apoptosis of cell lines carrying the mitochondrial DNA mutation.The in-depth evaluation of suspected mitochondrial diseaseDistinct functions of junD in cardiac hypertrophy and heart failureThe age-related accumulation of a mitochondrial DNA control region mutation in muscle, but not brain, detected by a sensitive PNA-directed PCR clamping based method.The role of PGC-1 coactivators in aging skeletal muscle and heart.Mitochondrial transfer RNAMet 4435A>G mutation is associated with maternally inherited hypertension in a Chinese pedigree.Failures in mitochondrial tRNAMet and tRNAGln metabolism caused by the novel 4401A>G mutation are involved in essential hypertension in a Han Chinese Family.A novel homoplasmic mutation in mtDNA with a single evolutionary origin as a risk factor for cardiomyopathyMetabolic cardiomyopathies.Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survival.Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy.The neuro-ophthalmology of mitochondrial diseaseEnergy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach.Sexual dimorphism in the expression of mitochondria-related genes in rat heart at different ages.The mitochondrial DNA mutations associated with cardiac arrhythmia investigated in an LQTS family.Butin (7,3',4'-trihydroxydihydroflavone) reduces oxidative stress-induced cell death via inhibition of the mitochondria-dependent apoptotic pathwayEndonuclease III and endonuclease VIII conditionally targeted into mitochondria enhance mitochondrial DNA repair and cell survival following oxidative stress.Estrogen-related receptor α (ERRα) and ERRγ are essential coordinators of cardiac metabolism and function.Private mitochondrial DNA variants in danish patients with hypertrophic cardiomyopathy.WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress.Protective effects of sirtuins in cardiovascular diseases: from bench to bedsideChronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage.Molecular mechanisms of life- and health-span extension: role of calorie restriction and exercise intervention.Telomeres and mitochondria in the aging heart.Primary myopathies and the heart.ROS and p53: a versatile partnershipPGC-1 coactivators in cardiac development and diseaseMitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course.Activation of PARP by oxidative stress induced by β-amyloid: implications for Alzheimer's disease.Calmodulin in a heartbeat.
P2860
Q24307610-D09BC94F-0E6F-4951-A629-B1C9A9934AEAQ24534480-BA9DB754-B819-426C-BAE3-5C003C4F7EBEQ26740355-C754B74F-A9C9-4CB8-8613-3BD52EA7931CQ26780547-86E0E27C-0592-406C-9435-9B0C2001F3A6Q27932161-0F5B7986-8FF9-4888-930B-FEBDC6AD6456Q28510070-E49E20F5-78E5-4CEB-8CB0-7C7677B5E933Q28609243-EF841716-2A68-4441-9315-9ABDB7C75A23Q30479303-5D843155-306C-44B4-8225-329109758F1CQ33435640-E5CD2140-3622-4214-9816-05D27A688CDBQ33515437-0CA2443A-490D-4CB0-A65B-CAE68B6926A8Q33608204-D1EC8FB1-062A-4AAB-B564-4626910DEF34Q33763691-90643305-1293-4267-951E-76557E9F9DDFQ33826111-DFEE041A-C39E-46AA-A82C-D823B076B94FQ33840188-565930F1-BABD-491F-8AA9-6514D88D1502Q34007628-B14166CE-F21F-4A8E-959A-73943EB03C21Q34007647-CC59D721-6686-46EB-BA23-8BD3B7764308Q34144436-6A368405-8FAC-4E53-A5EF-CC04F38DE43CQ34216280-9D8128F3-482D-48A1-A77D-D373BCBDACB4Q34311152-319123D2-0FC1-4BAE-820F-5F8C0F4CFD3CQ34311332-E742884C-5214-4DC8-8DFA-75174F590C69Q34338783-2FADE707-C45B-4A2D-87D8-1CBA56E06453Q34559786-0A1649F8-961B-4AB8-9B8E-19D16E8E3820Q35006906-6B72E45D-CFED-4A06-B1AC-2480C0D3851FQ35065160-A0F3D443-CEFA-41F4-8BD0-CEDF7056D493Q35091817-8FDC5F57-9AB9-4806-92FF-617CA91B4C37Q35131161-5EB71096-17E4-472C-9DCE-7D18077CCF56Q35165143-7B756830-95C1-42FE-9F49-BD65913D32D0Q35552917-ED2A7355-A2C4-4894-A4D1-35251838B2AEQ35601542-CD49C821-4394-4D5B-983B-4CD948E60DB5Q36338129-F463EF19-BF2B-433B-9169-A1745B132DC8Q36387714-C70F62F9-F853-44B3-B787-0E6A12B74B2FQ36808114-4635B402-A512-43FC-ACAF-93F3FF04389CQ37024657-5520145A-9163-4FA4-A93F-BC5776196DC8Q37033248-599FBED5-C063-433C-A6B7-4C86111B1AD8Q37084285-58B0F48F-51A9-415C-A05C-1DB288E14509Q37085000-AB0722B2-F100-4B60-A739-FEE09255B569Q37795417-68F95D5D-E064-43DA-89B7-DD316EA7D34AQ37970121-B0C48217-76D5-444F-BA53-8221C437F0A9Q38053106-8E25A067-38DB-4A1E-AB5E-38B6C6B8BC01Q38105647-477E61D8-5A35-4C2C-BB8E-6C319684FDDE
P2860
Mitochondrial defects in cardiomyopathy and neuromuscular disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Mitochondrial defects in cardiomyopathy and neuromuscular disease.
@ast
Mitochondrial defects in cardiomyopathy and neuromuscular disease.
@en
type
label
Mitochondrial defects in cardiomyopathy and neuromuscular disease.
@ast
Mitochondrial defects in cardiomyopathy and neuromuscular disease.
@en
prefLabel
Mitochondrial defects in cardiomyopathy and neuromuscular disease.
@ast
Mitochondrial defects in cardiomyopathy and neuromuscular disease.
@en
P356
P1476
Mitochondrial defects in cardiomyopathy and neuromuscular disease.
@en
P2093
Wallace DC
P304
P356
10.1067/MHJ.2000.103934
P407
P433
P577
2000-02-01T00:00:00Z